Laevorotatory antipode of moprolol as an antihypertensive

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4683245
SERIAL NO

06434362

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a process for the separation of moprolol into its two optical antipodes, substantially characterized by the fact of salifying racemic moprolol with L(+)glutamic acid; treating the thus obtained mixture of diastereoisomeric salts with a water/alcohol mixture, in this way separating the L(+)glutamate insoluble salt of (+)moprolol; treating the resultant mother liquors which contain in solution the L(+)glutamate salt of (-)moprolol with a base so as to separate the laevorotatory isomer of crystalline moprolol, which finally undergoes a purification. The invention also relates to a pharmaceutical composition containing said laevorotatoryisomer of moprolol.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZAMBON GROUP S P AVIA DELLA CHIMICA 9 VICENZA ITALY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferrari, Giorgio Milan, IT 29 134
Vecchietti, Vittorio Milan, IT 26 145

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation